1SB
TEVA icon

1ST Source Bank’s Teva Pharmaceuticals TEVA Stock Holding History

1ST Source Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,527
Closed -$316K – 228
2017
Q2 		$316K Sell
9,527
-1,017
-10% -$31.5K 0.03% 174
2017
Q1 		$338K Sell
10,544
-2,656
-20% -$90.6K 0.03% 174
2016
Q4 		$478K Sell
13,200
-2,676
-17% -$107K 0.05% 162
2016
Q3 		$731K Buy
15,876
+2,461
+18% +$128K 0.08% 125
2016
Q2 		$674K Sell
13,415
-1,201
-8% -$63.9K 0.08% 132
2016
Q1 		$782K Buy
14,616
+5
+0% +$293 0.09% 120
2015
Q4 		$959K Sell
14,611
-170
-1% -$10.5K 0.11% 108
2015
Q3 		$834K Sell
14,781
-235
-2% -$15.2K 0.1% 125
2015
Q2 		$887K Sell
15,016
-146
-1% -$9.01K 0.1% 123
2015
Q1 		$945K Hold
15,162
– – 0.11% 112
2014
Q4 		$872K Sell
15,162
-300
-2% -$16.7K 0.1% 113
2014
Q3 		$831K Sell
15,462
-1,306
-8% -$69.2K 0.11% 113
2014
Q2 		$879K Sell
16,768
-1,702
-9% -$87K 0.11% 113
2014
Q1 		$976K Sell
18,470
-16,998
-48% -$786K 0.13% 107
2013
Q4 		$1.42M Sell
35,468
-13,900
-28% -$547K 0.19% 91
2013
Q3 		$1.86M Sell
49,368
-2,842
-5% -$111K 0.28% 77
2013
Q2 		$2.05M Buy
+52,210
New +$2.03M 0.35% 63

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

1ST Source Bank's TEVA Position: Q3 2017 in Review

1ST Source Bank sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 9,527 shares — an estimated $316K sold.

1ST Source Bank first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $2.05M in Q2 2013. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • 1ST Source Bank reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • 1ST Source Bank sold 9,527 Teva Pharmaceuticals shares in Q3 2017, an estimated $316K.
  • 1ST Source Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • 1ST Source Bank's Teva Pharmaceuticals position peaked at $2.05M in Q2 2013.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on 1ST Source Bank's 13F filing for Q3 2017, filed 27 Oct 2017.